Spero Therapeutics, Inc. SPRO
Set alert
At close · Oct 30
After hours · Oct 30, 5:47 PM ET
- YTD
- -54.51%
- 1 year
- -55.08%
- Open
- 1.11
- Prev close
- 1.11
- Mkt cap
- 61.73M
- Vol
- 309.87K
- Avg vol
- 608.55K
- EPS
- 0.14
- P/E
- 7.57
- Div yield
- 0.00%
More statistics
- Low
- 1.05
- High
- 1.12
- Forward P/E
- -0.83
- Beta
- 0.63
- Short ratio
- 2.08
- Inst. own
- 23.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 1.20
- 200-d avg
- 1.38
- 1y target
- 5.00
5D chart
Signals (59)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 29, 3:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:40 AM | 2 days ago |
| RSI: Oversold | Oct 29, 11:20 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:45 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 12:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:50 AM | 3 days ago |
| RSI: Overbought | Oct 28, 11:25 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 11:20 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 10:05 AM | 3 days ago |
| RSI: Overbought | Oct 28, 9:40 AM | 3 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:25 PM | 4 days ago |
| RSI: Overbought | Oct 27, 1:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:35 PM | 4 days ago |
| RSI: Overbought | Oct 27, 11:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 26, 3:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:10 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:05 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 12:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 12:10 PM | 5 days ago |
| RSI: Oversold | Oct 26, 12:05 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 11:20 AM | 5 days ago |
| RSI: Oversold | Oct 26, 9:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 26, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 23, 4:00 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 3:50 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 3:00 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 2:45 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 2:10 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 2:00 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 1:55 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 1:35 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 12:50 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 12:35 PM | 1 week ago |
| RSI: Oversold | Oct 23, 11:20 AM | 1 week ago |
News
2 days ago benzinga.com
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
3 days ago benzinga.com
This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…
3 days ago benzinga.com
This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.
-
4 days ago benzinga.com
Cantor Fitzgerald Initiates Coverage On Spero Therapeutics with Overweight Rating, Announces Price Target of $6
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Spero Therapeutics (NASDAQ:SPRO) with a Overweight rating and announces Price Target of $6.
5 days ago globenewswire.com
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Amy Rock, Ph.D., appointed Chief Regulatory and Quality Officer, bringing extensive experience in global regulatory strategy, clinical development, and with approvals of novel immunotherapies Dae Gon…
1 month ago benzinga.com
Meta Platforms To $650? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised price targets for Meta, IREN, Coinbase, Roblox and others; IREN and Coinbase were upgraded, while other ratings held steady.
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals…
4 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
4 months ago benzinga.com
Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Smith & Wesson (SWBI) shares rose in pre-market trading after posting strong Q4 results, beating earnings and revenue estimates. Other gainers include LNKS, ADTX, and SPRO.
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
4 months ago benzinga.com
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs
FDA approves GSK and SPRO's Utebzi, the first oral carbapenem for cUTIs. Launch planned for late 2026. See market reaction.
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
4 months ago benzinga.com
GSK, Spero Therapeutics Announce FDA Approves Utebzi To Treat Complicated Urinary Tract Infections
https://www.gsk.com/en-gb/media/press-releases/utebzi-tebipenem-pivoxil-approved-in-the-us-for-adults-with-complicated-urinary-tract-infections-cutis/
-
7 months ago benzinga.com
Earnings Scheduled For March 26, 2026
Earnings Scheduled For March 26, 2026
-
11 months ago benzinga.com
Earnings Scheduled For November 13, 2025
Earnings Scheduled For November 13, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For August 12, 2025
Earnings Scheduled For August 12, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
1 year ago benzinga.com
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast
1 year ago benzinga.com
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings
-
1 year ago benzinga.com
Earnings Scheduled For November 14, 2024
Earnings Scheduled For November 14, 2024
-
2 years ago benzinga.com
Earnings Scheduled For March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
-
2 years ago benzinga.com
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 311 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 647 companies set new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
-
3 years ago benzinga.com
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
-
4 years ago benzinga.com
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
-
4 years ago benzinga.com
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 84 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 540 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 149 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 216 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 849 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 431 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 78 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 111 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For March 31, 2022
Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 729 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 348 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.